News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect ...
HHS announced that recommending COVID-19 vaccinations for healthy children and pregnant women would no longer be routine, ...
RFK Jr. will no longer recommend annual COVID-19 vaccines for healthy pregnant women and children, which has sparked much ...
The fact that the COVID-19 vaccine is not available for newborn babies is shielding a group of prisoners on Georgia’s death ...
A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
But in 2024, there was a prolonged summer surge in California that lasted from June through the end of September. After that ...
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback